Sustaining Meaningful Patient Engagement Across the Lifecycle of Medicines: A Roadmap for Action

Abstract

Background There is increased recognition that incorporating patients’ perspectives and insights into the medicines development process results in better health outcomes and benefits for all involved stakeholders. Despite the increased interest and the existence of frameworks and practical recommendations, patient engagement (PE) is not yet considered standard practice. The objective of this work was to provide a roadmap to support systematic change in all stakeholder organisations involved in medicines development across Europe, patients and patient organisations, medicines developers, academia, regulatory authorities, Health Technology Assessment bodies, payers, policy-makers and public research funders, to sustain PE practices. Methods A mixed-methods approach was used by the EU-funded Innovative Medicines Initiative PARADIGM Consortium to co-develop the sustainability roadmap including background work to identify success factors and scenarios for sustainable PE. The roadmap development was based on the Theory of Change concept and populated with findings from (1) interviews with national/ and international institutions with the potential to increase PE uptake by other stakeholders; (2) multi-stakeholder workshops and webinars; and (3) consultations with specific stakeholder groups, Consortium members and a consultative body formed by international PE initiatives. Results This roadmap sets strategic goals for the PE community to achieve meaningful and systematic PE through changes in the culture, processes and resources of stakeholder organisations. It brings in key PARADIGM outputs to work in a coordinated fashion with existing frameworks and mechanisms to achieve system-wide sustained PE. Conclusions The roadmap provides a framework for all stakeholders to take collective action within their organisations and across Europe to implement PE in a sustainable manner.

Engaging patients in patient safety: a qualitative study examining healthcare managers and providers’ perspectives

“…Common communication barriers identified by HCPs were role ambiguity, inadequate organizational support and not being trained to engage patients. This may be eliminated by having clear policies and guidelines in place to guide HCPs on how to engage patients in safety efforts [3,59]. Poor provider-patient communication also perceived as another barrier to patient participation in our study, consistent with previous research [24,60], indicating the importance of the HCPs' ability to communicate effectively with patients and families in order to engage them in safety-related behaviors [50].…”

Hidden in plain sight? Identifying patient-authored publications

“…Many stakeholders now recognize the importance of involving patients in research to understand diseases and to develop medicines [ 1 , 2 ]. Reflective of this change, patient advocates have started to author peer-reviewed publications from research across the medicine development life cycle [ 3 – 5 ].…”

Preventive pharmacological treatment in subjects at risk for fatal familial insomnia: science and public engagement

“…The engagement of patients as partners in healthcare research has gained consensus over the last two decades [ 51 , 52 ]. A number of reasons support the inclusion of patients as active partners in biomedical research and encourage funding to promote this participation.…”